Andreas Wicki is Director at Pacira Pharmaceuticals, Inc. (PCRX). They have made 33 open-market trades across 3 companies since 2011, most recently 2022-12-14.
CIK 0001511472
3 open-market purchases totalling $13.4M since 2011, against 30 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HRMY | SELL | 2022-12-12 | 2022-12-14 | $60.31 | $3.5M | -5.2% | -18.7% | -28.9% |
| HRMY | SELL | 2022-12-05 | 2022-12-07 | $61.23 | $9.5M | -7.7% | -10.4% | -27.8% |
| HRMY | SELL | 2022-11-14 | 2022-11-16 | $59.31 | $6.1M | +4.7% | +1.5% | -14.3% |
| HRMY | SELL | 2022-11-08 | 2022-11-10 | $58.89 | $15.2M | -0.6% | +3.0% | -16.2% |
| HRMY | SELL | 2022-11-02 | 2022-11-04 | $59.09 | $68.2M | -5.1% | +3.9% | -16.7% |
| HRMY | SELL | 2022-08-08 | 2022-08-10 | $53.77 | $62.2M | -10.3% | -10.0% | +12.3% |
| HRMY | SELL | 2022-08-03 | 2022-08-05 | $52.73 | $7.7M | -11.7% | -15.5% | +13.7% |
| HRMY | SELL | 2022-03-09 | 2022-03-11 | $45.16 | $19.5M | +12.5% | +7.6% | +6.3% |
| HRMY | SELL | 2022-03-01 | 2022-03-04 | $40.55 | $41.3M | +19.2% | +24.6% | +7.1% |
| HRMY | SELL | 2021-12-08 | 2021-12-10 | $40.09 | $2.2M | +12.9% | -1.1% | +20.8% |
| HRMY | SELL | 2021-11-15 | 2021-11-17 | $41.44 | $4.3M | -14.7% | +2.3% | -0.5% |
| PCRX | SELL | 2021-03-12 | 2021-03-16 | $73.19 | $10.2M | +1.6% | -6.1% | -15.0% |
| PCRX | SELL | 2021-03-09 | 2021-03-11 | $71.92 | $24.8M | -3.0% | -5.9% | -15.6% |
| PCRX | SELL | 2020-09-09 | 2020-09-11 | $62.02 | $275K | +0.7% | -1.7% | -1.6% |
| PCRX | SELL | 2020-08-11 | 2020-08-13 | $61.20 | $24.3M | -0.8% | -4.3% | -2.1% |
| VIE | BUY | 2019-10-07 | 2019-10-09 | $19.00 | $9.5M | +7.0% | +73.9% | +46.9% |
| PCRX | SELL | 2018-12-12 | 2018-12-14 | $46.84 | $1.4M | -7.8% | -16.7% | -12.9% |
| PCRX | SELL | 2018-11-19 | 2018-11-21 | $47.08 | $47K | +4.3% | -10.3% | -13.8% |
| PCRX | SELL | 2018-11-16 | 2018-11-19 | $46.83 | $1.2M | +6.0% | -3.0% | -12.4% |
| PCRX | SELL | 2018-11-15 | 2018-11-19 | $47.46 | $5.5M | +6.0% | -3.0% | -12.4% |
| PCRX | SELL | 2018-11-15 | 2018-11-19 | $47.63 | $2.1M | +6.0% | -3.0% | -12.4% |
| PCRX | SELL | 2018-11-12 | 2018-11-14 | $49.83 | $546K | -0.2% | -4.7% | -20.3% |
| PCRX | SELL | 2018-11-08 | 2018-11-13 | $51.12 | $5.9M | +1.4% | -4.6% | -21.4% |
| PCRX | SELL | 2014-08-28 | 2014-09-02 | $108.10 | $2.3M | -18.1% | +0.8% | +0.8% |
| PCRX | SELL | 2014-08-25 | 2014-08-27 | $108.09 | $6.0M | -18.1% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.